Navigation Links
Framingham Study Shows Parents Who Live Long Pass On Lower Risk of,Cardiovascular Disease

BETHESDA, Md., March 13, 2007--New evidence suggests that if you could choose your parents, you could reduce your risk of cardiovascular disease. Researchers from the long-standing Framingham Heart Study (FHS), a program of the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, report that people whose parents live longer were more likely to avoid developing high blood pressure, high cholesterol, and other risk factors for cardiovascular disease in middle age than their peers whose parents died younger. They also found that the risk factor advantages persisted over time.

According to the researchers, this is the first study to examine cardiovascular risk factors in the offspring of longer-lived individuals using independent and validated measurements of risk. The findings are consistent with other studies that have linked lower cardiovascular risk with parental longevity based on self-reports of family history.

"Characteristics of Framingham Offspring Participants with Long-Lived Parents, appears in the March 12 issue of the Archives of Internal Medicine.

In the study, researchers examined 1,697 offspring age 30 and older (average age 40) whose parents participated in the original FHS and had reached age 85 or died before January 1, 2005. They compared cardiovascular risk factors among the offspring based on whether both parents, one parent, or neither parent lived to 85 years or older. The risk factors included age, sex, education, cigarette smoking, blood pressure, cholesterol, and body mass index (BMI). In addition, they compared the offsprings' Framingham Risk Scores, a summary score based on the combined contribution of traditional cardiovascular risk factors.

In general, the group in which both parents survived to age 85 had significantly fewer participants with high blood pressure or who were current smokers, compared to those in which both
'"/>




Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/6/2015)... 2015 Saint-Gobain has acquired ZenPure, ... filtration products, mainly for the life sciences sector. ... in a state-of-the-art plant in Hangzhou, China ... the globe and will bolster the range of fluid ... acquisition is fully in line with the Group,s strategy ...
(Date:5/6/2015)...  Membership in Medicare Supplement plans continued to ... Strategy report released by Mark Farrah Associates (MFA).  ... Med Supp plans, covered approximately 11.2 million seniors ... from 2013. Between 2013 and 2014, enrollment in ... Though UnitedHealth was the segment growth leader, many ...
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/7qn2gf/global_insulin ) ... Insulin Patch Market Opportunity Analysis" report to ... ultrasound and iontophoresis are being used for the ... type of technique, their prices may vary which ... In long-term, it would be considered as inexpensive ...
Breaking Medicine Technology:Saint-Gobain Acquires ZenPure, a Specialist in Filtration Products 2Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2Global Insulin Patch Market Opportunity Analysis 2015 2
(Date:5/6/2015)... Lewisberry, PA (PRWEB) May 06, 2015 A quality ... option for a functional yet practical way to raise chickens on ... coop by Chicken Coop Condo, it will have a chicken tractor ... It will last for many years, as it is able to ... help control which areas of the land are fertilized, and it ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Chesapeake ... the state of Virginia to acquire Intuitive Surgical, ... robot. The system upgrade includes enhanced surgical technique ... invasive procedures across a wide spectrum of specialties. ... reduced pain and quicker recovery times. , “As ...
(Date:5/6/2015)... 2015 The Beryl Institute announces the ... Patient Experience Journal (PXJ), an international, open access, peer-reviewed ... and improving patient experience. The second volume of PXJ ... globally, helps align the voices engaged and provides the ... in association with The Beryl Institute, Volume 2, Issue ...
(Date:5/6/2015)... May 06, 2015 Is Colorado’s legal ... Next month the Centennial State will mark the 18-month ... sales to adults. And while Colorado’s legal marijuana industry ... that time, it’s also facing some new challenges. , ... currently facing shortages, especially in the wake of last ...
(Date:5/6/2015)... 2015 vcfo, a specialized consulting firm ... operational support to optimize business performance and productivity, announced ... and Michael Scheaffer. Both Lynch and Scheaffer have more ... , “We are delighted to add Jack and ... “Leveraging their background in financial management and leadership, Mike ...
Breaking Medicine News(10 mins):Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:vcfo Adds Two Senior Executives to Growing Team 2
... the President and CEO of the New Canadian EntityWHIPPANY, ... specialty pharmaceutical company, has announced today that it is ... Marketing (Canada) Ltd. This company will have its headquarters ... the marketing, sale and distribution of branded pharmaceutical products ...
... to "See the light on smokefree air"INDIANAPOLIS, March 3 ... today joined the fight to reduce the devastating effects ... legislators to pass a comprehensive smokefree law that protects ... leaders will march to the State House and assemble ...
... 3, 2009 UC Irvine neuroscientists have received $2 ... abilities. Study findings could lead to clinical research and ... autism. , UCI scientists hope to gain a greater ... located within the auditory cortex. , "We still don,t ...
... Misonix, Inc. (Nasdaq: MSON ), a ... in Europe is used for the ablation of tumors ... into a new, two year, sales agency agreement with ... for the representation of the Sonablate(R) SB500 High Intensity ...
... Center for Women and Justice at Cornell ... to End Violence Against Women Award-Winning Actress Reese Witherspoon ... One in three women worldwide experience violence in their ... every nine seconds(2). Around the world, services for victims ...
... SalesNOVATO, Calif., March 3 BioMarin Pharmaceutical Inc. (Nasdaq: ... warning letter issued to Genzyme addressing deficiencies related to ... in September and October 2008 has no foreseeable impact ... does not require Genzyme to recall or quarantine product. ...
Cached Medicine News:Health News:Halo Pharmaceutical Launches a Branded Product Marketing Company in Canada 2Health News:Indiana's Faith, Health Leaders Join Push for Comprehensive Smokefree Law 2Health News:Misonix Announces New Sales Agency Agreement for Eastern Europe 2Health News:Misonix Announces New Sales Agency Agreement for Eastern Europe 3Health News:Misonix Announces New Sales Agency Agreement for Eastern Europe 4Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 2Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 3Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 4Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 5Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 6Health News:FDA Warning Letter to Genzyme Related to the Allston Manufacturing Facility 2Health News:FDA Warning Letter to Genzyme Related to the Allston Manufacturing Facility 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: